China, Nov. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'MRI-Based Multi-Task Deep Learning for Pancreatic Ductal Adenocarcinoma Segmentation, Localization, and Pathological TNM Staging Prediction'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600137191
Registration Time: 2026/11/19
Type: Observational study
Primary Sponsor: Huzhou Center Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=350896
Published by HT Digital Content Services with permission from Health Daily Digest....